Literature DB >> 11277593

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis.

T T Rohn1, S M Wong, C W Cotman, D H Cribbs.   

Abstract

Although considerable research has shown a role for peroxisome proliferator-activated receptors (PPAR) in adipose differentiation and in the regulation of inflammation, little is known about its possible functions in neurons. We investigated the role of PPARgamma in primary cultures of cortical neurons and human neuroblastoma SH-SYSY cells. Incubation of cortical neurons with the specific PPARgamma ligand 15-Deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) induced morphological changes including neurite degeneration and nuclear condensation that were consistent with neurons dying by apoptosis. The morphological changes associated with incubation of cortical neurons with 15d-PGJ2 were prevented following pretreatment of neurons with the general caspase inhibitor, Z-VAD. These results highlight a novel role for PPARgamma in neurons and suggest that unwarranted activation of PPARgamma may contribute to the neuronal apoptosis associated with certain neurodegenerative disorders including Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277593     DOI: 10.1097/00001756-200103260-00043

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  27 in total

1.  Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Authors:  Erik S Musiek; Rebecca S Breeding; Ginger L Milne; Giuseppe Zanoni; Jason D Morrow; Bethann McLaughlin
Journal:  J Neurochem       Date:  2006-04-21       Impact factor: 5.372

Review 2.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

3.  Manganese treatment modulates the expression of peroxisome proliferator-activated receptors in astrocytoma and neuroblastoma cells.

Authors:  Alfred Orina Isaac; Ivana Kawikova; Alfred L M Bothwell; Christopher K Daniels; James C K Lai
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

4.  Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.

Authors:  Anna L Bartels; Klaus L Leenders
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 5.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

6.  Increased generation of cyclopentenone prostaglandins after brain ischemia and their role in aggregation of ubiquitinated proteins in neurons.

Authors:  Hao Liu; Wenjin Li; Muzamil Ahmad; Marie E Rose; Tricia M Miller; Mei Yu; Jie Chen; Jordan L Pascoe; Samuel M Poloyac; Robert W Hickey; Steven H Graham
Journal:  Neurotox Res       Date:  2013-01-25       Impact factor: 3.911

7.  Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells.

Authors:  Helen A Rodway; Alan N Hunt; Janice A Kohler; Anthony D Postle; Karen A Lillycrop
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

8.  Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.

Authors:  Tatsurou Yagami
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

9.  CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage.

Authors:  Yasmilde Rodriguez Gonzalez; Yi Zhang; Doreh Behzadpoor; Sean Cregan; Simon Bamforth; Ruth S Slack; David S Park
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

10.  In vivo effects of rosiglitazone in a human neuroblastoma xenograft.

Authors:  I Cellai; G Petrangolini; M Tortoreto; G Pratesi; P Luciani; C Deledda; S Benvenuti; C Ricordati; S Gelmini; E Ceni; A Galli; M Balzi; P Faraoni; M Serio; A Peri
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.